...
首页> 外文期刊>Pharmaceutical development and technology >Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels.
【24h】

Development and in vitro evaluation of insulin-loaded buccal Pluronic F-127 gels.

机译:胰岛素载口腔Pluronic F-127凝胶的开发和体外评估。

获取原文
获取原文并翻译 | 示例

摘要

Insulin-loaded buccal Pluronic F-127 (PF-127) gel formulations were fabricated to study the effect of PF-127 concentration, insulin concentration, presence of salt, addition of polymer, and permeation enhancer on their gelation time, mucoadhesion force, release and permeation characteristics of insulin from the gels. Thereafter, the principle of statistical optimization to prepare a gel formulation having the potential for buccal delivery of basal insulin in diabetic patients was employed. The gelation time decreased as the concentration of PF-127 increased. Presence of salts as well as addition of polymer, such as methyl cellulose (MC) and hydroxypropylmethyl cellulose (HPMC) decreased the gelation time. An increase in PF-127 concentration and addition of MC and HPMC increased the mucoadhesion force of the gel formulations. Release and permeation of insulin from the gel formulations decreased with increased concentration of PF-127, presence of salts, and addition of MC and HPMC. Permeation of insulin from the optimized gel formulation was 93.17 (+/- 0.058, n = 3) microg/cm(2) which was not only found in close agreement with predicted results from the model equations used for the formulation optimization but also considered comparable to clinical setting. Therefore, the development of optimized buccal insulin-loaded Pluronic F-127 gels using a statistical experimental design is feasible.
机译:制备了含胰岛素的口腔Pluronic F-127(PF-127)凝胶配方,以研究PF-127浓度,胰岛素浓度,盐的存在,聚合物的添加和渗透促进剂对其胶凝时间,粘膜粘附力,释放的影响和胰岛素从凝胶中的渗透特性。此后,采用统计学优化的原理来制备具有在糖尿病患者中经颊递送基础胰岛素的潜力的凝胶制剂。胶凝时间随着PF-127浓度的增加而减少。盐的存在以及聚合物的添加,例如甲基纤维素(MC)和羟丙基甲基纤维素(HPMC)减少了胶凝时间。 PF-127浓度的增加以及MC和HPMC的添加增加了凝胶制剂的粘膜粘附力。胰岛素从凝胶制剂中的释放和渗透随着PF-127浓度的增加,盐的存在以及MC和HPMC的添加而降低。优化凝胶配方中胰岛素的渗透率为93.17(+/- 0.058,n = 3)microg / cm(2),不仅与配方优化所用模型方程的预测结果非常吻合,而且被认为具有可比性到临床环境。因此,使用统计实验设计开发优化的含颊胰岛素的Pluronic F-127凝胶是可行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号